As always, you are on the money! Orphan drug status for Hema! Min technology right behind it. All the naysaying is rubbish to get cheap shares! This is a slam dunk! Even if takes until the end of the year for approval, won't it all be worth it! Don't be blinded by the day traders creating smoke and mirrors! Long bmsn! We will come out winning folks!